Laboratory News and Research

RSS

AI-designed molecular switch uses caffeine to control engineered cells

For many of us, a warm cup of coffee is how we start our day. For Texas A&M Health researchers, it may also offer a new way to control engineered cells in future medicines.

8 Jun 2026

$3.8 million grant funds study on early lung immune responses to tuberculosis

A University of Minnesota Medical School research team was awarded a 5-year, $3.8 million grant from the National Institute of Allergy and Infectious Diseases to study early immune responses in the lung and how they influence tuberculosis infection outcomes.

8 Jun 2026

New genetic disorder linked to severe childhood lung disease

A new report in the American Journal of Human Genetics describes a novel disorder caused by biallelic loss-of-function variants in the TMEM63B gene, which results in severe lung disease.

8 Jun 2026

New project launches to advance chikungunya vaccine in Africa

Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.

8 Jun 2026

Expert review examines widely-held beliefs about dietary protein needs and benefits

A newly published peer-reviewed paper in Critical Reviews in Food Science and Nutrition synthesizes findings from a February 2025 scientific workshop.

8 Jun 2026

Infant receives world's first gene therapy for WOREE syndrome

An eight-month-old infant with a severe genetic epilepsy has become the first patient in the world to receive an experimental gene replacement therapy designed to restore the function of the WWOX gene directly in the brain.

8 Jun 2026

Africa CDC and WHO unite to combat Ebola outbreak

The Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO) today launched a joint continental preparedness and response plan on the ongoing Ebola outbreak caused by the Bundibugyo virus.

7 Jun 2026

Study reveals how germinal centers consistently produce antibodies

A new study tracking thousands of B cells across more than 100 germinal centers in mice reveals how the system consistently produces highly effective antibodies.

7 Jun 2026

Antibody fragment offers safer alternative for Alzheimer disease treatment

In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (Leqembi, from Biogen) and donanemab (KisunlaTM, from Eli Lilly and Company), both based on immunotherapy (the use of molecules from the immune system to treat diseases).

5 Jun 2026

Biopsy-driven treatment strategy improves clinical outcomes in psoriatic arthritis

The management of psoriatic arthritis is increasingly focused on the early identification of clinical, immunological, and tissue-based phenotypes predictive of therapeutic response.

5 Jun 2026

Study reveals distinct sociodemographic risk factors in rare myopathies

Idiopathic inflammatory myopathies (IIM) are a heterogenous group of autoimmune conditions with substantial morbidity.

5 Jun 2026

Revolutionizing calibration: How Lumo uses machine learning to streamline E&L screening and toxicological risk assessment

Lumo leverages advanced machine learning to reduce calibration time, and flag low-confidence response factor predictions.

From Jordi Labs 5 Jun 2026

Scientists discover new intracellular immune defense against infections

When we think of the immune system, most people imagine white blood cells putting up a fight against invading germs within our bloodstream.

4 Jun 2026

Amplified Sciences secures investment for pancreatic cyst diagnostic assay

Amplified Sciences, a clinical-stage diagnostics company pioneering next-generation multi-omic assays, today announced a new investment from the American Gastroenterological Association's (AGA) GI Opportunity Fund as part of its recent Seed+ financing round.

4 Jun 2026

Study reveals how breast cancer cells hide in the bone marrow

Treating breast cancer remains a major medical challenge worldwide. This is largely due to the ability of breast cancer cells to remain hidden for years before triggering a relapse, which can occur even decades after successful treatment of the primary tumor.

4 Jun 2026